AIG
JBIO

American International Group’s Jade Biosciences JBIO Stock Holding History

American International Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-157
Closed -$163K – 265
2024
Q1 		$163K Sell
157
-2
-1% -$1.53K ﹤0.01% 2265
2023
Q4 		$126K Hold
159
– – ﹤0.01% 2430
2023
Q3 		$75.7K Buy
159
+21
+15% +$11.4K ﹤0.01% 2664
2023
Q2 		$83.1K Buy
138
+11
+9% +$7.04K ﹤0.01% 2697
2023
Q1 		$89.4K Buy
127
+3
+2% +$2.49K ﹤0.01% 2511
2022
Q4 		$127K Sell
124
-1
-0.8% -$726 ﹤0.01% 2395
2022
Q3 		$72K Buy
125
+2
+2% +$1.33K ﹤0.01% 2695
2022
Q2 		$67K Sell
123
-63
-34% -$30.1K ﹤0.01% 2771
2022
Q1 		$119K Buy
186
+33
+22% +$12.8K ﹤0.01% 2520
2021
Q4 		$63K Sell
153
-5
-3% -$2.53K ﹤0.01% 2885
2021
Q3 		$116K Buy
+158
New +$88.5K ﹤0.01% 2736

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return